Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Evette Mitkov

Moderna Stock Is Moving Higher Tuesday: Here's Why

Augsburg,,Bavaria,,Germany,-,March,21,,2021:,Vials,With,The

Moderna, Inc. (NASDAQ:MRNA) shares are up nearly 5% on Tuesday after the company announced positive preliminary immunogenicity data for its 2025-2026 Spikevax formula, which targets the new LP.8.1 variant of COVID-19.

What Happened: The Phase 4 clinical trial that’s currently underway — covering the safety, tolerability and immunogenicity of the 2025-2026 Spikevax formula — showed positive results.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.